These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 482342)

  • 1. Plasma protein displacement interactions are rarely of clinical significance.
    Sellers EM
    Pharmacology; 1979; 18(5):225-7. PubMed ID: 482342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding displacement interactions and their clinical importance.
    McElnay JC; D'Arcy PF
    Drugs; 1983 May; 25(5):495-513. PubMed ID: 6345130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions involving the displacement of drugs from plasma protein and tissue binding sites.
    D'Arcy PF; McElnay JC
    Pharmacol Ther; 1982; 17(2):211-20. PubMed ID: 6757977
    [No Abstract]   [Full Text] [Related]  

  • 4. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of drug binding, protein binding, and binding displacement drug interactions.
    DeVane CL
    Psychopharmacol Bull; 2002; 36(3):5-21. PubMed ID: 12473961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding displacement interactions--why are they still regarded as clinically important?
    Rolan PE
    Br J Clin Pharmacol; 1994 Feb; 37(2):125-8. PubMed ID: 8186058
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug interactions].
    Brummer R; Horsch W; Pfeifer S; Süss W
    Pharmazie; 1979 Apr; 34(4):260-3. PubMed ID: 482341
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of drug displacement interactions.
    Aarons LJ; Rowland M
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):181-90. PubMed ID: 7277208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of antirheumatic preparations].
    Reinicke C; Wessel G
    Ter Arkh; 1984; 56(5):14-9. PubMed ID: 6379966
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.
    Palatini P; Orlando R; De Martin S
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1215-30. PubMed ID: 20604736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic and molecular processes in the mechanism of action of general anesthetics].
    Fateev VA; Saliaev VN; Titov NS; Diunov AG; Aristov AV
    Farmakol Toksikol; 1983; 46(1):107-15. PubMed ID: 6130968
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of non-steroidal anti-inflammatory drugs on plasma protein binding of corticosterones (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1978; 28(10):1714-23. PubMed ID: 385004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the significance of warfarin protein-binding displacement interactions.
    Sands CD; Chan ES; Welty TE
    Ann Pharmacother; 2002 Oct; 36(10):1642-4. PubMed ID: 12369572
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein binding drug displacement interactions fact or fiction?
    MacKichan JJ
    Clin Pharmacokinet; 1989 Feb; 16(2):65-73. PubMed ID: 2656044
    [No Abstract]   [Full Text] [Related]  

  • 16. Displacement of rifampicin bound to serum proteins by addition of levamisole.
    Pérez-Gallardo L; Blanco ML; Soria H; Escanero JF
    Biomed Pharmacother; 1992; 46(4):173-4. PubMed ID: 1421049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The interaction of drug agents].
    Kukes VG; Lemina EIu; Rumiantsev AS
    Farmakol Toksikol; 1991; 54(2):82-5. PubMed ID: 1884808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of 4-hydroxycoumarin derivative anticoagulants (a review of the literature)].
    Lakin KM; Krylov IuF; Kuperman AV; Grenaderov SIu
    Farmakol Toksikol; 1981; 44(4):484-94. PubMed ID: 7026279
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug?
    Pellegatti M; Pagliarusco S; Solazzo L; Colato D
    Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):1009-20. PubMed ID: 21635153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.